证券日报网讯 金禾实业8月21日在互动平台回答投资者提问时表示，公司在合成生物领域已构建了合成 生物创新平台，通过自主研发与产学研合作，掌握了菌种改造、发酵工艺优化及产物分离纯化等核心技 术，并依托合成生物学基地开展非粮生物基材料原料化利用、食品配料、日化香料等萜类衍生物的研发 储备。目前，萜类香料项目中，瓦伦西亚橘烯等高附加值香料产品已完成中试放大工艺验证，正在落实 工业化生产方案的探索，并进一步做好降本增效的工作。公司将持续巩固在生物合成领域的技术优势与 市场布局。 （编辑 袁冠琳） ...

Core Viewpoint - The company has made significant progress in the field of terpene biosynthesis, establishing an innovative platform for synthetic biology and focusing on high-value products like Valencia orange oil [2] Group 1: Research and Development - The company has built a synthetic biology innovation platform through independent research and collaboration with academic and research institutions [2] - Key technologies mastered include strain modification, fermentation process optimization, and product separation and purification [2] - The company is developing non-grain bio-based materials, food ingredients, and daily chemical fragrances derived from terpenes [2] Group 2: Project Status - The high-value fragrance products, such as Valencia orange oil, have completed pilot-scale process validation [2] - The company is exploring industrial production solutions and focusing on cost reduction and efficiency improvement [2] - The company aims to strengthen its technological advantages and market presence in the field of biosynthesis [2]